Amedisys Inc
NASDAQ:AMED

Watchlist Manager
Amedisys Inc Logo
Amedisys Inc
NASDAQ:AMED
Watchlist
Price: 100.99 USD 0.01%
Market Cap: $3.3B

Wall St Price Targets

AMED Price Targets Summary
Amedisys Inc

There are no price targets for AMED.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Amedisys Inc Competitors:
Price Targets
APO
Apollo Global Management Inc
25% Upside
TNDM
Tandem Diabetes Care Inc
86% Upside
YUMC
Yum China Holdings Inc
43% Upside
BLFS
BioLife Solutions Inc
14% Upside
DVA
DaVita Inc
-14% Downside

Revenue
Forecast

4% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
4% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 6%.

Gross Profit
Forecast

3% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
3% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%.

Operating Income
Forecast

5% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
5% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 12%.

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AMED's stock price target?
Not Available

AMED does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Amedisys Inc?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 6%.

What is the Operating Income forecast for Amedisys Inc?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett